Sticky

By:
On:
In: International Journal Integrative Oncology Vol.2. No.1 2008
With: 0 Comments

Qing Lin*, Jing Gong, Dongjun Yang, Yan Zhou, Chunyang Li, Xianfeng Sun, Zhiqiang Cao Department of Thoracic Surgery, The 1st Hospital of Yichun, Yichun, Heilongjiang Province 153000, China ABSTRACT OBJECTIVE To study surgery treatment strategies and outcomes in stage IIIA NSCLC (No pleural effusion) with adjuvant PandiMex naturopathic therapy. METHODSContinue Reading

Sticky

By:
On:
In: International Journal Integrative Oncology Vol.2. No.1 2008, Original Article
With: 0 Comments

Ji Tan *, Yangyan Sun, Daoyuan Wang Department of Gynaecology, Jiangyin Hospital, Medical school of Southeast University, Jiangyin City. Jiangsu Province, PR China BACKGROUND To compare the operative data and early postoperative outcomes for myomectomy performed by isobaric gasless laparoscopically with those by minilaparotomy (MLT) isobaric gasless laparoscopy (LA) inContinue Reading

By:
On:
In: International Journal Integrative Oncology Vol.2. No.1 2008, Original Article
With: 0 Comments

Yun Liu, Yufei Yang*, Yu Wu, Juan Liao Department of Oncology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing 100091, China ABSTRACT OBJECTIVE To investigate the mechanisms of KangLaite Injection (KLT, a new anti-cancer drug) in the treatment of tumor by using CTL immune-related gene chip technique. METHODS AContinue Reading

Sticky

By:
On:
In: International Journal Integrative Oncology Vol.2. No.1 2008, Review Article
With: 0 Comments

Tsu-Tsair Chi, PhD ABSTRACT Angiogenesis inhibition has been a major breakthrough in cancer research and is undoubtedly one of the reasons for the decline in cancer incidence and mortality. In cases of estrogen-related cancers, the use of aromatase inhibitors has been quite successful in reducing recurrence and improving overall survivalContinue Reading

By:
On:
In: International Journal Integrative Oncology Vol.2. No.1 2008, People Notes
With: 0 Comments

Dr. Jia-Xin Qiu obtained his M.D. at Shanghai Second Medical College (Now known as Medical College of Shanghai Jiao Tong University) in Shanghai in 1960. In the same year, he was recruited into Longhua Hospital, affiliated to Shanghai Traditional Chinese Medicine College (Now known as Shanghai University of Traditional ChineseContinue Reading

By:
On:
In: International Journal Integrative Oncology Vol.2. No.1 2008, Viewpoint Article
With: 0 Comments

Zhiguo Zhao, PhD Department of Acupuncture and Massage, Hebei Medical University, Shijiazhuang 050091 P. R. China The incidence of malignant cancer is increasing gradually in recent years, and cancer has become as a major risk for human well-being. According to WHO updated statistics, an estimated 80 to 100 million cancerContinue Reading

By:
On:
In: International Journal Integrative Oncology Vol.2. No.1 2008, Viewpoint Article
With: 0 Comments

Sherman Zhao, MD, PhD WHAT CONSTITUTES SUPPORT THERAPY? Most oncology professionals agree that support is a multidimensional construct encompassing provision of therapeutic agents, information, emotional support, material aid, and services. Supportive measures that could improve quality of life include the use of biologically based therapies (erythropoiesis stimulation agents (ESA), G-CSF,Continue Reading

By:
On:
In: Dr. Jack He, Editorial, International Journal Integrative Oncology Vol.2. No.1 2008
With: 0 Comments

Dr. Jack He, MD, MSc, RAc To date, cancer treatment regimen is most likely to be a combination of standardization and individualization. It is about integrating individual clinical expertise and the best external evidence. Thereby oncologists can improve the treatment of cancer by integration of evidence-based medicine and customized cancerContinue Reading